A recent study assessed the safety and efficacy of a wireless communication system between a leadless pacemaker and a subcutaneous implantable cardioverter-defibrillator in patients at risk for sudden cardiac death due to ventricular arrhythmias.
Despite treating older, sicker patients and performing more non-elective surgeries, osteopathic surgeons achieved comparable 30-day mortality rates to their allopathic counterparts, with no significant differences in readmissions or length of stay.
The FDA approved VYALEV for the treatment of motor fluctuations in adults with advanced Parkinson's disease, marking the first subcutaneous 24-hour continuous infusion of levodopa-based therapy approved for this indication.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A recent study in JAMA Internal Medicine revealed that acupuncture significantly reduced chronic sciatica pain compared to sham acupuncture, with lasting benefits of up to 52 weeks.
FDA approves Avadel Pharmaceuticals' once-nightly dosing sleep disorder drug, Lumryz, for children aged 7 years and older, offering a new option for narcolepsy treatment.
A recent study in JAMA Health Forum found that patients treated by altruistic physicians had lower healthcare spending and were less likely to experience preventable hospital admissions and emergency department visits.